GV 2019 GP, L.L.C.
CIK 1845038 · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GOOGL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MOUNTAIN VIEW, CA 94043
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GOOGL | 10%+ Owner | 0 | $288.15 | $0 | -$23.47M | 16 | 2026-05-18 |
| PRME | 10%+ Owner | 0 | $4.30 | $0 | -$1.89M | 1 | 2023-05-24 |
| Verve Therapeutics, Inc. (VERV) Delisted | 10%+ Owner | 4,260,047 | $11.13 | $47.41M | -$9.53M | 3 | 2022-11-08 |
| IonQ, Inc. (IONQ.WS) Delisted | 4,556,532 | $33.55 | $152.87M | $0 | 1 | 2022-04-12 |
Recent Filings · Page 3 of 3
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-22 | Verve Therapeutics, Inc. (VERV) Delisted | Conv (C) | +4,472,509 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.